Pfizer nabs $13.5B in U.S. bond issue

No one can accuse Pfizer leadership of timidity. With the nation mired in a deep recession, the company Tuesday launched the second largest U.S.-dollar bond issue in history, a $13.5 billion offering to help fund its $68 billion acquisition of Wyeth. (It's exceeded only by Roche's recent $16 billion for its Genentech buy.) Report

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Incyte and Novartis' Jakafi is eying a nod in chronic graft vs. host disease—and it may just have the data to get it done.

With a slate of vaccine authorizations on the horizon, vaccine execs from a trio of leading shot makers are looking at distribution hurdles ahead.

News of an FDA plant inspection for a Macrogenics drug boosted investor confidence in BMS' ability to meet its year-end deadline for liso-cel.